Asthma drug could halve chance of developing Parkinson’s

News

Author: Parkinson's Life editorsPublished: 28 September 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Asthma medication

A recent study has found that a drug most commonly used for asthma may cut the chances of developing Parkinson’s.

The research, carried out by Harvard Medical School, Massachusetts, US, found that those who inhaled salbutamol – a drug found in inhalers – were half as likely to develop the condition.

In Parkinson’s disease, a protein named a-synuclein accumulates in various brain cells and can be fatal. To counter this, the research team grew human nerve cells and tested over 1000 medications, finding results to suggest salbutamol could cut the production of a-synuclein.

Neurologist Anthony Lang, who works at the University of Toronto, Canada, said the results were “fascinating” and “had come out of the blue”.

Despite some encouraging developments, Clemens Scherzer, who was a part of the research team, said clinical trials were “a few years off”.

Go Back

Share this story

Comments


Related articles


A closeup of a farmer's hands harvesting a crop.

Global update

Environmental Protection Agency bans pesticide linked to Parkinson’s disease

The US organisation has prohibited the use of chlorpyrifos

READ MORE
Michael J Fox book cover

Global update

Michael J Fox opens up about living with Parkinson’s disease

The ‘Back to the Future’ star discusses his latest book

READ MORE
Darcy Blake lead

Interviews

Why I set up a Parkinson’s support group that’s just for women

Women-only group openly talks about sexuality & other issues

READ MORE